232 related articles for article (PubMed ID: 31638246)
1. Weighted gene coexpression analysis indicates that PLAGL2 and POFUT1 are related to the differential features of proximal and distal colorectal cancer.
Lv Y; Xie B; Bai B; Shan L; Zheng W; Huang X; Zhu H
Oncol Rep; 2019 Dec; 42(6):2473-2485. PubMed ID: 31638246
[TBL] [Abstract][Full Text] [Related]
2. PLAGL2 and POFUT1 are regulated by an evolutionarily conserved bidirectional promoter and are collaboratively involved in colorectal cancer by maintaining stemness.
Li D; Lin C; Li N; Du Y; Yang C; Bai Y; Feng Z; Su C; Wu R; Song S; Yan P; Chen M; Jain A; Huang L; Zhang Y; Li X
EBioMedicine; 2019 Jul; 45():124-138. PubMed ID: 31279780
[TBL] [Abstract][Full Text] [Related]
3. A network-based predictive gene expression signature for recurrence risks in stage II colorectal cancer.
Yang WJ; Wang HB; Wang WD; Bai PY; Lu HX; Sun CH; Liu ZS; Guan DK; Yang GW; Zhang GL
Cancer Med; 2020 Jan; 9(1):179-193. PubMed ID: 31724326
[TBL] [Abstract][Full Text] [Related]
4. Identifying the key genes and microRNAs in colorectal cancer liver metastasis by bioinformatics analysis and in vitro experiments.
Zhang T; Guo J; Gu J; Wang Z; Wang G; Li H; Wang J
Oncol Rep; 2019 Jan; 41(1):279-291. PubMed ID: 30542696
[TBL] [Abstract][Full Text] [Related]
5. POFUT1 and PLAGL2 gene pair linked by a bidirectional promoter: the two in one of tumour progression in colorectal cancer?
Germot A; Maftah A
EBioMedicine; 2019 Aug; 46():25-26. PubMed ID: 31378697
[No Abstract] [Full Text] [Related]
6. Hypermethylated and downregulated MEIS2 are involved in stemness properties and oxaliplatin-based chemotherapy resistance of colorectal cancer.
Wang X; Ghareeb WM; Zhang Y; Yu Q; Lu X; Huang Y; Huang S; Sun Y; Chi P
J Cell Physiol; 2019 Aug; 234(10):18180-18191. PubMed ID: 30859572
[TBL] [Abstract][Full Text] [Related]
7. Identification of Prognostic Biomarker Signatures and Candidate Drugs in Colorectal Cancer: Insights from Systems Biology Analysis.
Rahman MR; Islam T; Gov E; Turanli B; Gulfidan G; Shahjaman M; Banu NA; Mollah MNH; Arga KY; Moni MA
Medicina (Kaunas); 2019 Jan; 55(1):. PubMed ID: 30658502
[TBL] [Abstract][Full Text] [Related]
8. Application of weighted gene co‑expression network analysis to explore the potential diagnostic biomarkers for colorectal cancer.
Qin L; Zeng J; Shi N; Chen L; Wang L
Mol Med Rep; 2020 Jun; 21(6):2533-2543. PubMed ID: 32323816
[TBL] [Abstract][Full Text] [Related]
9. Overexpressed PLAGL2 transcriptionally activates Wnt6 and promotes cancer development in colorectal cancer.
Li N; Li D; Du Y; Su C; Yang C; Lin C; Li X; Hu G
Oncol Rep; 2019 Feb; 41(2):875-884. PubMed ID: 30535429
[TBL] [Abstract][Full Text] [Related]
10. Identification of hub genes in colorectal cancer based on weighted gene co-expression network analysis and clinical data from The Cancer Genome Atlas.
Zhang Y; Luo J; Liu Z; Liu X; Ma Y; Zhang B; Chen Y; Li X; Feng Z; Yang N; Feng D; Wang L; Song X
Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34308980
[TBL] [Abstract][Full Text] [Related]
11. Integrative Gene Expression Profiling Analysis to Investigate Potential Prognostic Biomarkers for Colorectal Cancer.
Liu X; Bing Z; Wu J; Zhang J; Zhou W; Ni M; Meng Z; Liu S; Tian J; Zhang X; Li Y; Jia S; Guo S
Med Sci Monit; 2020 Jan; 26():e918906. PubMed ID: 31893510
[TBL] [Abstract][Full Text] [Related]
12. Identification of biomarkers associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis.
Chen L; Lu D; Sun K; Xu Y; Hu P; Li X; Xu F
Gene; 2019 Apr; 692():119-125. PubMed ID: 30654001
[TBL] [Abstract][Full Text] [Related]
13. Identification of key genes associated with colorectal cancer based on the transcriptional network.
Chen G; Li H; Niu X; Li G; Han N; Li X; Li G; Liu Y; Sun G; Wang Y; Li Z; Li Q
Pathol Oncol Res; 2015 Jul; 21(3):719-25. PubMed ID: 25613817
[TBL] [Abstract][Full Text] [Related]
14. Pleomorphic adenoma gene like-2 induces epithelial-mesenchymal transition via Wnt/β-catenin signaling pathway in human colorectal adenocarcinoma.
Wang YP; Guo PT; Zhu Z; Zhang H; Xu Y; Chen YZ; Liu F; Ma SP
Oncol Rep; 2017 Apr; 37(4):1961-1970. PubMed ID: 28259923
[TBL] [Abstract][Full Text] [Related]
15. Molecular characterization of colorectal adenomas reveals POFUT1 as a candidate driver of tumor progression.
Komor MA; de Wit M; van den Berg J; Martens de Kemp SR; Delis-van Diemen PM; Bolijn AS; Tijssen M; Schelfhorst T; Piersma SR; Chiasserini D; Sanders J; Rausch C; Hoogstrate Y; Stubbs AP; de Jong M; Jenster G; Carvalho B; Meijer GA; Jimenez CR; Fijneman RJA;
Int J Cancer; 2020 Apr; 146(7):1979-1992. PubMed ID: 31411736
[TBL] [Abstract][Full Text] [Related]
16. Follistatin-Like 3 Correlates With Lymph Node Metastasis and Serves as a Biomarker of Extracellular Matrix Remodeling in Colorectal Cancer.
Yang C; Cao F; Huang S; Zheng Y
Front Immunol; 2021; 12():717505. PubMed ID: 34335633
[TBL] [Abstract][Full Text] [Related]
17. Role of COL6A3 in colorectal cancer.
Liu W; Li L; Ye H; Tao H; He H
Oncol Rep; 2018 Jun; 39(6):2527-2536. PubMed ID: 29620224
[TBL] [Abstract][Full Text] [Related]
18. Coexpression network analysis linked H2AFJ to chemoradiation resistance in colorectal cancer.
Wang X; Ghareeb WM; Lu X; Huang Y; Huang S; Chi P
J Cell Biochem; 2019 Jun; 120(6):10351-10362. PubMed ID: 30565747
[TBL] [Abstract][Full Text] [Related]
19. High stromal nicotinamide N-methyltransferase (NNMT) indicates poor prognosis in colorectal cancer.
Song M; Li Y; Miao M; Zhang F; Yuan H; Cao F; Chang W; Shi H; Song C
Cancer Med; 2020 Mar; 9(6):2030-2038. PubMed ID: 31989785
[TBL] [Abstract][Full Text] [Related]
20. Gasdermin C Is Upregulated by Inactivation of Transforming Growth Factor β Receptor Type II in the Presence of Mutated Apc, Promoting Colorectal Cancer Proliferation.
Miguchi M; Hinoi T; Shimomura M; Adachi T; Saito Y; Niitsu H; Kochi M; Sada H; Sotomaru Y; Ikenoue T; Shigeyasu K; Tanakaya K; Kitadai Y; Sentani K; Oue N; Yasui W; Ohdan H
PLoS One; 2016; 11(11):e0166422. PubMed ID: 27835699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
